Evofem Bioscience Inc (EVFM)
[[ item.lastPrice ]] [[ item.priceChange ]] ([[ item.percentChange ]]) [[ item.tradeTime ]] [OTC US]
[[ item.bidPrice ]] x [[ item.bidSize ]] [[ item.askPrice ]] x [[ item.askSize ]]
[[ session ]] by (Cboe BZX)
[[ item.lastPrice ]] [[ item.priceChange ]] ([[ item.percentChange ]]) [[ item.tradeTime ]] [OTC US]
[[ item.bidPrice ]] x [[ item.bidSize ]] [[ item.askPrice ]] x [[ item.askSize ]]
[[ session ]] [[ item.lastPriceExt ]] [[ item.priceChangeExt ]] ([[ item.percentChangeExt ]]) [[ item.tradeTimeExt ]]
for [[ item.sessionDateDisplayLong ]]
Fiscal Year End Date: 12/31
| 06-2023 | 03-2023 | 12-2022 | 09-2022 | 06-2022 | |
| Sales | 2,458 | 5,809 | 181 | 6,371 | 6,034 |
| Cost of Goods | 2,293 | 1,376 | 384 | 1,680 | 1,285 |
| Gross Profit | 165 | 4,433 | -203 | 4,691 | 4,749 |
| Operating Expenses | 7,794 | 8,388 | 12,233 | 24,095 | 29,453 |
| Operating Income | -7,336 | -3,579 | -12,052 | -18,724 | -24,419 |
| Other Income | -1,219 | 1,228 | 3,724 | 108,243 | -101,541 |
| Pre-tax Income | -8,555 | -2,351 | -8,328 | 89,519 | -125,960 |
| Income Tax | 3 | 3 | 14 | 13 | 20 |
| Net Income Continuous | -8,558 | -2,354 | -8,342 | 89,506 | -125,980 |
| Net Income | $-8,558 | $-2,354 | $-8,336 | $89,506 | $-125,980 |
| EPS Basic Total Ops | -5.43 | -1.85 | 637.59 | 135.72 | -580.48 |
| EPS Basic Continuous Ops | -5.43 | -1.85 | 639.43 | 135.72 | -580.48 |
| EPS Diluted Total Ops | -5.43 | -1.85 | 777.70 | -4.39 | -580.48 |
| EPS Diluted Continuous Ops | -5.43 | -1.85 | 755.00 | 20.15 | -580.48 |
| EBITDA(a) | $-6,459 | $-2,830 | $-11,802 | $-18,474 | $-24,169 |